Investments
217Portfolio Exits
84Downsview Capital Investments
217 Investments
Downsview Capital has made 217 investments. Their latest investment was in Cascadian Therapeutics as part of their PIPE on February 2, 2011.
Downsview Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
2/11/2011 | PIPE | Cascadian Therapeutics | $0.15M | Yes | ||
8/22/2008 | PIPE - II | Arotech | $5M | No | ||
8/22/2008 | PIPE - II | LightPath Technologies | $2.93M | No | ||
8/8/2008 | PIPE - II | |||||
8/5/2008 | PIPE |
Date | 2/11/2011 | 8/22/2008 | 8/22/2008 | 8/8/2008 | 8/5/2008 |
|---|---|---|---|---|---|
Round | PIPE | PIPE - II | PIPE - II | PIPE - II | PIPE |
Company | Cascadian Therapeutics | Arotech | LightPath Technologies | ||
Amount | $0.15M | $5M | $2.93M | ||
New? | Yes | No | No | ||
Co-Investors | |||||
Sources |
Downsview Capital Portfolio Exits
84 Portfolio Exits
Downsview Capital has 84 portfolio exits. Their latest portfolio exit was Antares Pharma on May 24, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
5/24/2022 | Acq - P2P | 5 | |||
12/19/2019 | Acquired | 6 | |||
3/9/2018 | Acq - P2P | 4 | |||
Date | 5/24/2022 | 12/19/2019 | 3/9/2018 | ||
|---|---|---|---|---|---|
Exit | Acq - P2P | Acquired | Acq - P2P | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 5 | 6 | 4 |
Downsview Capital Acquisitions
1 Acquisition
Downsview Capital acquired 1 company. Their latest acquisition was Ventyx on January 18, 1999.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
1/18/1999 | Acquired |
Date | 1/18/1999 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired |
Sources |
Downsview Capital Team
1 Team Member
Downsview Capital has 1 team member, including current President, Mitchell P. Kopin.
Name | Work History | Title | Status |
|---|---|---|---|
Mitchell P. Kopin | President | Current |
Name | Mitchell P. Kopin |
|---|---|
Work History | |
Title | President |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.